Sunday 11 October 2026
Export all HCSG data to Excel Powerpack
Healthcare Services Group, Inc.
HCSG Healthcare Medical Care Facilities
Healthcare Services Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, up 7.08% from fiscal 2024. In the quarter to June 2026, revenue grew 2.69%, EPS grew 175.0% and free cash flow fell 26.0%, each against the same quarter a year earlier. Dividend growth for ten consecutive years.
20.59
0.07
−0.34%
Follow HCSG
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
14.20 | 19.32 | 23.32 | 31.17 |
+8 more quarters Free account |
P/S ratio |
0.91 | 0.70 | 0.75 | 0.67 | |
P/FCF ratio |
11.36 | 8.31 | 9.94 | 7.69 | |
P/Operating CF |
77.22 | 29.63 | 79.59 | 17.05 | |
P/B ratio |
3.25 | 2.52 | 2.71 | 2.45 | |
Price to Tangible BV |
4.02 | 3.03 | 3.27 | 2.98 | |
EV/Sales |
0.81 | 0.60 | 0.66 | 0.57 | |
EV/EBITDA |
10.57 | 14.50 | 18.37 | 19.20 | |
EV/Operating CF |
9.81 | 6.86 | 8.31 | 6.31 | |
EV/FCF |
10.17 | 7.10 | 8.65 | 6.54 | |
Quick Ratio |
2.79 | 2.88 | 3.16 | 2.74 | |
Current Ratio |
3.02 | 3.11 | 3.38 | 2.97 | |
Net Debt/EBITDA |
(7.80) | (5.69) | (6.87) | (4.15) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
2.30 | 2.26 | 2.30 | 2.25 | |
Operating CF/Net income |
0.96 | 1.68 | 0.56 | 1.66 | |
Capex/Depreciation |
(0.44) | (0.35) | (0.36) | (0.32) | |
Interest Coverage |
35.88 | 92.70 | 69.18 | 116.70 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
11.17% | 9.08% | 9.90% | 10.88% | |
Intangible Assets out of Total Assets |
0.12 | 0.11 | 0.11 | 0.11 | |
Share Based Compensation of Revenue |
0.60% | 0.60% | 0.67% | 0.56% | |
Graham Net Nets |
0.16 | 0.23 | 0.21 | 0.22 | |
Graham Number |
17.14 | 12.60 | 11.40 | 9.13 | |
Earnings Yield |
7.04% | 5.18% | 4.29% | 3.21% | |
Free Cash Flow Yield |
8.81% | 12.03% | 10.06% | 13.00% | |
Revenue per Share |
6.85 | 6.62 | 6.45 | 6.43 | |
Operating CF per Share |
0.32 | 0.63 | 0.24 | 0.99 | |
Capex per Share |
(0.02) | (0.02) | (0.02) | (0.02) | |
Free Cash Flow per Share |
0.30 | 0.61 | 0.22 | 0.97 | |
Cash per Share |
2.92 | 3.07 | 2.82 | 2.87 | |
Shareholders Equity per Share |
7.55 | 7.35 | 7.05 | 6.87 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.55 | 7.35 | 7.05 | 6.87 | |
Free Cash Flow |
20.33 | 42.39 | 16.03 | 69.97 | |
Working Capital |
380.41 | 407.86 | 406.04 | 384.99 | |
Capital Expenditures |
(1.54) | (1.34) | (1.36) | (1.33) | |
Net Current Asset Value |
266.51 | 300.15 | 292.37 | 272.34 | |
EV/EBIT |
11.84 | 18.63 | 24.83 | 28.35 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
13.22 | 21.83 | 28.51 | 33.36 | |
| Other line items | |||||
Average Receivables |
323.99 | 364.88 | 358.56 | 367.99 | |
Average Payables |
82.00 | 80.95 | 79.26 | 79.18 | |
Average Inventory |
16.60 | 16.58 | 16.77 | 17.12 | |
Average Assets |
811.53 | 818.90 | 798.51 | 805.07 | |
Average Common Equity |
497.94 | 513.98 | 505.07 | 492.38 |
Columns are period end dates